PANTANO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 1.287
NA - Nord America 761
EU - Europa 420
SA - Sud America 13
OC - Oceania 12
AF - Africa 8
Totale 2.501
Nazione #
SG - Singapore 836
US - Stati Uniti d'America 736
HK - Hong Kong 196
CN - Cina 170
IT - Italia 125
GB - Regno Unito 118
DE - Germania 45
IN - India 34
NL - Olanda 27
CA - Canada 20
CZ - Repubblica Ceca 19
FR - Francia 14
FI - Finlandia 13
JP - Giappone 13
TR - Turchia 13
AU - Australia 12
BR - Brasile 9
EE - Estonia 9
AT - Austria 8
ID - Indonesia 8
UA - Ucraina 8
ZA - Sudafrica 8
KR - Corea 6
RU - Federazione Russa 5
MX - Messico 4
RO - Romania 4
SA - Arabia Saudita 4
BE - Belgio 3
DK - Danimarca 3
ES - Italia 3
GR - Grecia 3
PT - Portogallo 3
CL - Cile 2
LV - Lettonia 2
RS - Serbia 2
SE - Svezia 2
AM - Armenia 1
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MS - Montserrat 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
YE - Yemen 1
Totale 2.501
Città #
Singapore 286
Ashburn 203
Hong Kong 195
Boardman 169
Shanghai 113
London 112
Los Angeles 34
Rome 34
San Francisco 32
Pune 24
Toronto 20
Brno 18
Amsterdam 17
Council Bluffs 17
Redmond 16
Seattle 15
Washington 14
Helsinki 13
Munich 10
Canberra 6
Xi'an 6
Chicago 5
Hyderabad 5
Melbourne 5
Naples 5
Paris 5
Yeonsu-gu 5
Brooklyn 4
Padova 4
Riyadh 4
Sona 4
São Paulo 4
Vienna 4
West Jordan 4
Athens 3
Copenhagen 3
Durham 3
Mexico City 3
Miami 3
Milan 3
Montesilvano Marina 3
Ningbo 3
Oklahoma City 3
Pescara 3
Porto 3
Tokyo 3
Ankara 2
Anyang 2
Beijing 2
Caluire-et-Cuire 2
Charlotte 2
Ferrara di Monte Baldo 2
Genoa 2
Gragnano 2
Haikou 2
Johannesburg 2
Karthaus 2
Kragujevac 2
Lyon 2
Madrid 2
Moscow 2
New York 2
Oniferi 2
Prineville 2
Riga 2
Salt Lake City 2
Santa Clara 2
Scafati 2
Trieste 2
Wuhan 2
Yuncheng 2
Zhengzhou 2
Agordo 1
Amman 1
Bari 1
Berlin 1
Brussels 1
Budapest 1
Cagliari 1
Campina Grande 1
Centurion 1
Changchun 1
Charleston 1
Chisinau 1
Clifton 1
Costabissara 1
Dallas 1
Dalsjoefors 1
Detroit 1
Dezhou 1
Dorchester 1
Ferrara 1
Forest City 1
Fort Worth 1
Frankfurt am Main 1
Guangzhou 1
Guiyang 1
Haifa 1
Handan 1
Hanover 1
Totale 1.528
Nome #
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 52
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 49
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 32
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 30
Anterior and posterior vaginal myomectomy: A new surgical technique 28
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 28
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 28
Premetastatic niche: ready for new therapeutic interventions? 27
Biological effects of cabozantinib on bone microenvironment 27
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 27
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 26
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 26
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 25
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 25
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 25
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 25
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 24
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 24
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 24
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 23
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 23
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 23
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 23
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 23
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 22
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 22
Molecular prognostic factors in patients with pancreatic cancer 22
Designing a broad-spectrum integrative approach for cancer prevention and treatment 22
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 22
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 21
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 21
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 21
Denosumab for cancer-related bone loss 21
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 21
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 20
Bone Health in Cancer Patients 20
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 20
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 20
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 20
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 20
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 20
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 20
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 20
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 19
New targets, new drugs for metastatic bone pain: a new philosophy 19
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 19
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 18
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 18
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 18
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 18
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 18
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 17
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 17
New developments of aminobisphosphonates: the double face of Janus 17
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 17
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 17
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 17
CETUXIMAB: From bench to bedside 17
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 16
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 16
TUMORI NEUROENDOCRINI 16
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 16
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 16
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 16
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 16
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 16
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 15
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 15
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 15
The role of bone microenvironment, vitamin D and calcium 15
Monoclonal antibodies 15
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 15
Facing SARS-CoV-2 outbreak in immunotherapy era 15
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 15
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 15
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 15
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 15
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 15
Osteoporosis 2014 15
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 15
Bone metastases in biliary cancers: A multicenter retrospective survey 14
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 14
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 14
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 14
Targeting bone metastases starting from the preneoplastic niche: home sweet home 14
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 14
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 14
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 14
Emerging Therapeutic Targets in Osteoncology 14
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 14
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 14
Deregulation of dicer and mir-155 expression in liposarcoma 14
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 14
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 14
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 14
Targeting bone metastases: New drugs for new targets 14
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 14
Prognostic and predictive factors in pancreatic cancer 14
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 14
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 14
Totale 1.946
Categoria #
all - tutte 48.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20251.732 76 92 206 49 39 137 115 31 491 456 40 0
Totale 2.631